ZTS FY 2015 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.8B-0.4% YoY

Gross Profit

$3.0B62.3% margin

Operating Income

$1.1B22.7% margin

Net Income

$339M7.1% margin

EPS (Diluted)

$0.68

Cash Flow

Operating Cash Flow

$664M

Free Cash Flow

$440M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$7.9B

Total Liabilities

$6.8B

Stockholders' Equity

$1.1B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.8B	$4.8B	-0.4%
Gross Profit	$3.0B	$3.0B	-1.4%
Operating Income	$1.1B	$970M	+11.5%
Net Income	$339M	$583M	-41.9%